Sit Investment Associates’s abrdn Life Sciences Investors HQL Stock Holding History

Sit Investment Associates’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-417,064	Closed	-$5.47M	–	534
2024 Q4	$5.47M	Hold	417,064	–	–	0.12%	193
2024 Q3	$6.29M	Buy	417,064 +224,420	+116%	+$3.4M	0.14%	179
2024 Q2	$2.73M	Buy	+192,644	New	+$2.61M	0.06%	260
2014 Q3	–	Sell	-397,457	Closed	-$8.25M	–	444
2014 Q2	$8.25M	Buy	397,457 +365,957	+1,162%	+$7.68M	0.14%	157
2014 Q1	$685K	Buy	+31,500	New	+$701K	0.01%	367

Other funds holding HQL

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

AIA

Absolute Investment Advisers Rosemary Beach, Florida $1.03B AUM 1% 1-Year Est. Return

Sit Investment Associates's HQL Position: Q1 2025 in Review

Sit Investment Associates sold out of abrdn Life Sciences Investors (HQL) in Q1 2025, closing a stake of 417,064 shares — an estimated $5.47M sold.

Sit Investment Associates first reported a position in HQL in Q1 2014 and held it in 5 quarters. The position peaked at $8.25M in Q2 2014. 82 funds tracked by Wall St. Rank hold HQL as of Q1 2025.

Sit Investment Associates reported no remaining abrdn Life Sciences Investors position as of Q1 2025 after selling out during the quarter.
Sit Investment Associates sold 417,064 abrdn Life Sciences Investors shares in Q1 2025, an estimated $5.47M.
Sit Investment Associates first reported a position in abrdn Life Sciences Investors in Q1 2014 and held it in 5 quarters.
Sit Investment Associates's abrdn Life Sciences Investors position peaked at $8.25M in Q2 2014.
82 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2025.

Based on Sit Investment Associates's 13F filing for Q1 2025, filed 13 May 2025.